quinoxalines has been researched along with Fibrosis in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Chen, Z; Dai, G; Gan, Y; He, Y; Li, B; Ru, F; Xia, W; Zhang, B | 1 |
| Basta, MD; Paulson, H; Walker, JL | 1 |
| Abergel, A; Andant, N; Asselah, T; Bailly, F; Buchard, B; Chanteranne, B; Di Martino, V; Dodel, M; Faure, F; Fouchard-Hubert, I; Gournay, J; Lamblin, G; Larrey, D; Loustaud-Ratti, V; Mallat, A; Muti, L; Pereira, B; Pol, S; Reymond, M; Samuel, D; Teilhet, C; Tran, A | 1 |
| Chen, L; Feng, Y; Gan, H; Haydon, RC; He, TC; Huang, B; Huang, S; Lei, J; Liu, W; Luo, W; Luu, HH; Shu, Y; Wang, X; Xia, Y; Yan, S; Yu, X; Yuan, C; Zeng, L; Zeng, Z; Zhang, B; Zhang, H; Zhang, L; Zhang, R; Zhang, X; Zhao, C | 1 |
| Asatryan, A; Beyer, J; Campbell, A; Collins, C; Dekhtyar, T; Irvin, M; Kort, J; Krishnan, P; Lawitz, EJ; Lovell, S; Lu, L; Mensa, F; Ng, TI; Pilot-Matias, T; Reisch, T; Schnell, G; Tripathi, R; Yao, B | 1 |
| Liu, W; Lovell, S; Mensa, FJ; Pilot-Matias, T | 1 |
| Brandan, E; Contreras, O; Faundez-Contreras, J; González, D; Lipson, KE; Murphy-Ullrich, JE; Rebolledo, DL; Vio, CP | 1 |
| Alexander, R; Blanchard, A; Chambers, RC; Datta, A; Forty, EJ; Hayes, B; Mercer, PF; Scotton, CJ | 1 |
| Baker, AH; Denby, L; McBride, M; Ramdas, V | 1 |
| Aurora, AB; Baker, AH; Conway, BR; Delles, C; Denby, L; Dickinson, B; Grant, JS; Kipgen, D; Lu, R; McClure, JD; Ramdas, V; van Rooij, E | 1 |
| Aguilar, H; Asatryan, A; Gane, E; Hassanein, T; Kort, J; Kwo, PY; Lalezari, J; Lin, CW; Liu, R; Maliakkal, B; Mensa, FJ; Ng, TI; Poordad, F; Wang, S; Wyles, DL | 1 |
| Choi, MJ; Han, JY; Hong, SS; Jin, HR; Kim, DK; Kim, IH; Kim, SJ; Kim, WJ; Lee, CR; Lee, SJ; Mamura, M; Park, SH; Piao, S; Ryu, JK; Shin, HY; Suh, JK; Zhang, LW | 1 |
| Hu, XH; Jiang, W; Li, Y; Qing, Y; Song, LF; Tong, QY; Wu, XH | 1 |
| Dunkern, TR; Feurstein, D; Hatzelmann, A; Rossi, GA; Sabatini, F | 1 |
| Adamson, RH; Dalgard, DW; Farb, A; Snyderwine, EG; Sugimura, T; Takayama, S; Thorgeirsson, SS; Thorgeirsson, UP; Virmani, R | 1 |
| Böhmer, FD; Kosmehl, H; Ludewig, D; Sommer, M; Stein, G | 1 |
1 review(s) available for quinoxalines and Fibrosis
| Article | Year |
|---|---|
Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C virus infection.
Topics: Aminoisobutyric Acids; Antiviral Agents; Benzimidazoles; Coinfection; Cyclopropanes; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Fibrosis; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Lactams, Macrocyclic; Leucine; Proline; Protease Inhibitors; Pyrrolidines; Quinoxalines; Renal Insufficiency, Chronic; Sulfonamides; Treatment Outcome | 2019 |
3 trial(s) available for quinoxalines and Fibrosis
| Article | Year |
|---|---|
Phase 3, Multicenter Open-Label study to investigate the efficacy of elbasvir and grazoprevir fixed-dose combination for 8 weeks in treatment-naïve, HCV GT1b-infected patients, with non-severe fibrosis.
Topics: Adult; Aged; Amides; Antiviral Agents; Asia; Benzofurans; Carbamates; Cyclopropanes; Drug Therapy, Combination; Europe; Female; Fibrosis; Genotype; Hepacivirus; Hepatitis C; Humans; Imidazoles; Male; Middle Aged; Quinoxalines; Ribavirin; Sulfonamides | 2020 |
Resistance Analysis of a 3-Day Monotherapy Study with Glecaprevir or Pibrentasvir in Patients with Chronic Hepatitis C Virus Genotype 1 Infection.
Topics: Amino Acid Substitution; Aminoisobutyric Acids; Antiviral Agents; Benzimidazoles; Cyclopropanes; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Fibrosis; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Leucine; Liver; Proline; Pyrrolidines; Quinoxalines; RNA, Viral; Sulfonamides; Viral Load | 2018 |
High Efficacy of ABT-493 and ABT-530 Treatment in Patients With HCV Genotype 1 or 3 Infection and Compensated Cirrhosis.
Topics: Aminoisobutyric Acids; Antiviral Agents; Benzimidazoles; Cyclopropanes; Drug Therapy, Combination; Female; Fibrosis; Genotype; Hepacivirus; Hepatitis C; Humans; Lactams, Macrocyclic; Leucine; Male; Middle Aged; Proline; Pyrrolidines; Quinoxalines; Ribavirin; Sulfonamides; Sustained Virologic Response | 2016 |
12 other study(ies) available for quinoxalines and Fibrosis
| Article | Year |
|---|---|
Liproxstatin-1 attenuates unilateral ureteral obstruction-induced renal fibrosis by inhibiting renal tubular epithelial cells ferroptosis.
Topics: Animals; Carbolines; Cell Death; Cell Line; Cell Proliferation; Cell Shape; Collagen; Disease Models, Animal; Epithelial Cells; Ferroptosis; Fibrosis; Humans; Iron; Kidney Tubules; Lipid Peroxidation; Male; Mice, Inbred C57BL; Myofibroblasts; Phospholipid Hydroperoxide Glutathione Peroxidase; Quinoxalines; Spiro Compounds; Ureteral Obstruction | 2021 |
The local wound environment is a key determinant of the outcome of TGFβ signaling on the fibrotic response of CD44
Topics: Actins; Animals; Blotting, Western; Capsule Opacification; Cataract Extraction; Cell Proliferation; Chick Embryo; Collagen Type I; Disease Models, Animal; Fibronectins; Fibrosis; Hyaluronan Receptors; Imidazoles; Integrin alphaVbeta3; Microscopy, Fluorescence; Myofibroblasts; Posterior Capsule of the Lens; Postoperative Complications; Pyrazoles; Pyrroles; Quinoxalines; Receptor, Transforming Growth Factor-beta Type I; Signal Transduction; Transforming Growth Factor beta; Wound Healing | 2021 |
A blockade of PI3Kγ signaling effectively mitigates angiotensin II-induced renal injury and fibrosis in a mouse model.
Topics: Angiotensin II; Animals; Cell Proliferation; Class Ib Phosphatidylinositol 3-Kinase; Cytokines; Disease Models, Animal; Fibroblasts; Fibrosis; Kidney; Mice; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Quinoxalines; Renal Insufficiency, Chronic; Thiazolidinediones | 2018 |
Denervation-induced skeletal muscle fibrosis is mediated by CTGF/CCN2 independently of TGF-β.
Topics: Animals; Antibodies, Monoclonal, Humanized; Benzamides; Connective Tissue Growth Factor; Dioxoles; Extracellular Matrix; Fibrosis; Gene Expression Regulation; Imidazoles; Male; Mice; Models, Animal; Muscle Denervation; Muscle, Skeletal; Quinoxalines; Signal Transduction; Transforming Growth Factor beta | 2019 |
Ex vivo micro-computed tomography analysis of bleomycin-induced lung fibrosis for preclinical drug evaluation.
Topics: Animals; Bleomycin; Chromatography, High Pressure Liquid; Collagen; Disease Models, Animal; Disease Progression; Drug Evaluation, Preclinical; Fibrosis; Humans; Imidazoles; Lung; Male; Mice; Mice, Inbred C57BL; Protein Serine-Threonine Kinases; Pulmonary Fibrosis; Quinoxalines; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Treatment Outcome; X-Ray Microtomography | 2013 |
Canonical transforming growth factor-β signaling regulates disintegrin metalloprotease expression in experimental renal fibrosis via miR-29.
Topics: Animals; Cell Line; Disintegrins; Fibrosis; Gene Expression Regulation, Enzymologic; Glomerulonephritis; Imidazoles; Male; Mice; MicroRNAs; Quinoxalines; Rats; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta | 2013 |
MicroRNA-214 antagonism protects against renal fibrosis.
Topics: Animals; Disease Models, Animal; Fibrosis; Gene Deletion; Gene Expression; Humans; Imidazoles; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Quinoxalines; Renal Insufficiency, Chronic; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta; Ureteral Obstruction | 2014 |
IN-1130, a novel transforming growth factor-beta type I receptor kinase (activin receptor-like kinase 5) inhibitor, promotes regression of fibrotic plaque and corrects penile curvature in a rat model of Peyronie's disease.
Topics: Animals; Disease Models, Animal; Fibrosis; Humans; Imidazoles; Male; Penile Induration; Penis; Protein Kinase Inhibitors; Quinoxalines; Rats | 2009 |
[The antagonistic effect of PI3K-gamma inhibitor AS605240 on cardiac hypertrophy and cardiac fibrosis induced by isoproterenol in rats].
Topics: Animals; Cardiomegaly; Fibrosis; Isoproterenol; Male; Myocardium; Proteasome Endopeptidase Complex; Proteins; Quinoxalines; Random Allocation; Rats; Rats, Wistar; Thiazolidinediones | 2011 |
Inhibition of TGF-beta induced lung fibroblast to myofibroblast conversion by phosphodiesterase inhibiting drugs and activators of soluble guanylyl cyclase.
Topics: Actins; Benzamides; Benzoates; Blotting, Western; Cell Differentiation; Cells, Cultured; Cyclic GMP; Dinoprostone; Drug Synergism; Enzyme Activators; Fibroblasts; Fibrosis; Guanylate Cyclase; Humans; Immunohistochemistry; Isoenzymes; Lung; Myocytes, Smooth Muscle; Natriuretic Peptide, Brain; Nitric Oxide Donors; Nitroso Compounds; Oxadiazoles; Phosphodiesterase Inhibitors; Piperazines; Purines; Pyridines; Quinoxalines; Receptors, Cytoplasmic and Nuclear; Sildenafil Citrate; Soluble Guanylyl Cyclase; Sulfones; Transforming Growth Factor beta | 2007 |
Studies on the carcinogenic and myocardial effects of 2-amino-3-methylimidazo [4,5-f] quinoline (IQ) in nonhuman primates.
Topics: Administration, Oral; Animals; Carcinogens; Cooking; DNA Adducts; Fibrosis; Heart; Hot Temperature; Humans; Imidazoles; Inflammation; Liver Neoplasms; Liver Neoplasms, Experimental; Lung Neoplasms; Macaca fascicularis; Meat; Myocardium; Necrosis; Quinolines; Quinoxalines | 1995 |
PDGF receptor kinase blocker AG1295 attenuates interstitial fibrosis in rat kidney after unilateral obstruction.
Topics: Actins; Animals; Biomarkers; Fibronectins; Fibrosis; Kidney; Nephritis, Interstitial; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Platelet-Derived Growth Factor; Ureteral Obstruction | 2000 |